EP Patent

EP0699655B1 — Process for the preparation of quaternary diesters

Assigned to Akzo Nobel NV · Expires 1997-09-24 · 29y expired

What this patent protects

Disclosed is a process for the preparation of quaternary diesters of the formula: <CHEM> wherein X<-> represents a halogen atom, notably a chlorine atom or a bromine atom, R1 and R2 may be the same or different and have the meaning of an alkyl group having 1 to 3 car…

USPTO Abstract

Disclosed is a process for the preparation of quaternary diesters of the formula: <CHEM> wherein X<-> represents a halogen atom, notably a chlorine atom or a bromine atom, R1 and R2 may be the same or different and have the meaning of an alkyl group having 1 to 3 carbon atoms, a hydroxyethyl group, or be linked together to form an alkylene group having 4 to 6 carbon atoms which may be interrupted by an N atom or O atom, and R3 and R4 may be the same or different and have the meaning of an alkyl group or alkenyl group having 8 to 22 carbon atoms, or be linked together to form an alk(en)ylene group having 8 to 22 carbon atoms, characterised in that a) a secondary amine of the formula R1-NH-R2 is gradually added to and converted with one or more liquid compounds of the formula <CHEM> at a molar ratio in the range of 1,0 : 1,0 and 1,0 : 1,2, after which b) the formed solid amine hydrohalide is separated, followed by c) an aftertreatment, optionally in a solvent, at elevated temperature until the conversion is virtually complete, after which, if so desired, further treatments, such as recrystallisation from an organic solvent, are carried out to achieve a special product form.

Drugs covered by this patent

Patent Metadata

Patent number
EP0699655B1
Jurisdiction
EP
Classification
Expires
1997-09-24
Drug substance claim
No
Drug product claim
No
Assignee
Akzo Nobel NV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.